A Limulus Antilipopolysaccharide Factor-Derived Peptide Exhibits a New Immunological Activity with Potential Applicability in Infectious Diseases

Previous studies have shown that cyclic peptides corresponding to residues 35 to 52 of the Limulus antilipopolysaccharide (anti-LPS) factor (LALF) bind and neutralize LPS-mediated in vitro and in vivo activities. Therapeutic approaches based on agents which bind and neutralize LPS activities are par...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Clin Diagn Lab Immunol
Egile Nagusiak:	Vallespi, Maribel G., Glaria, Luis A., Reyes, Osvaldo, Garay, Hilda E., Ferrero, Joel, Araña, Manuel J.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2000
Gaiak:	Microbial Immunology
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95932/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10882670/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.7.4.669-675.2000
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!